Benchmark analyst Bruce Jackson reiterated a Hold rating and {REMOVEPT} price target on Neogenomics (NASDAQ: NEO).The analyst commented, “For full-year ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE